The Board

Introduction to the IML team, our Board of Directors and the experts and members of our various working groups with whom we collaborate.

The Board of Directors sets IML's strategic priorities, its key objectives and approves IML's policy positions, thus ensuring good governance and alignment of IML's public policies in a local context.

Team

RL Portrait

Romain Labé

Secrétaire général
AB

Aurélie Boob

Public Affairs Associate
AV

Anna Vasalou

European and legal affairs Manager

Board

BMS

Bart Croes

Administrator - Bristol-Myers Squibb
Gregory Willocq

Gregory Willocq

Lead Task Force Public Affairs - Abbvie
Ziad Matta

Ziad Matta

Co-Lead Task Force Gouvernance - Servier
Frédéric Clais

Frédéric Clais

Administrator - Eli Lilly
Jean-Michel Luyckx

Jean-Michel Luyckx

Co-Lead Task Force Public Affairs - Novartis
Aan Adrienne

Ann Adriaensen

Independant Administrator - pharma.be
Stéphane Soulard

Stéphane Soulard

Lead Task Force Gouvernance - Boehringer-Ingelheim
RobertHenkinet

Robert Henkinet

Administrator - Johnson & Johnson Innovative Medicine
Nadia

Nadia Van der Plaetsen

Lead Task Force Public Health - Novo Nordisk Pharma

Task Force Market Access

Sébastien Massart

Lead Task Force Market Access - Eli Lilly
Become a member

Interested in becoming a partner?

To benefit from all of our services, more particularly :

  • Participate in committees and commissions, in the different working groups
  • Free access to our intranet
  • Profit of the organizations networh:  exchangres between experts, invitation to formations and exclusive meetings (economical, scientific, industrial, social, legal, RSE, parlementary, european, communication…)
  • Being represented and being defended in front of institutions and the public, see the image of drug producing companies valued.

for more detailed information about the adhesion steps, please, contact us by mail contact@iml.lu .